8-K - Mineralys Therapeutics, Inc. (0001933414) (Filer)
Published . Updated .
Filed: 2026-10-19 AccNo: 0001933414-26-000125 Size: 146 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Directly affected
- MLYS Mineralys Therapeutics
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-19 AccNo: 0001933414-26-000125 Size: 146 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial St…
Source: sec-edgar
Mineralys Therapeutics (MLYS) since “8-K - Mineralys Therapeutics, Inc. (0001933414) (Filer),” compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | -0.39% | still updating |
| GLD | three days earlier | +0.80% | final price |
| GLD | five days earlier | +0.53% | final price |
| Mineralys Therapeutics (MLYS) | that day | +3.45% | still updating |
| Mineralys Therapeutics (MLYS) | three days earlier | +3.49% | final price |
| Mineralys Therapeutics (MLYS) | five days earlier | +0.57% | final price |
| QQQ | that day | +0.14% | still updating |
| QQQ | three days earlier | +1.38% | final price |
| QQQ | five days earlier | +3.53% | final price |
| SPY | that day | +0.38% | still updating |
| SPY | three days earlier | +0.67% | final price |
| SPY | five days earlier | +1.49% | final price |
| TLT | that day | +0.69% | still updating |
| TLT | three days earlier | +0.67% | final price |
| TLT | five days earlier | -1.40% | final price |
Who is named in “8-K - Mineralys Therapeutics, Inc. (0001933414) (Filer)”
Companies carried with this story
- MLYS Mineralys Therapeutics
For “8-K - Mineralys Therapeutics, Inc. (0001933414) (Filer),” Mineralys Therapeutics (MLYS) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> MLYS
How “8-K - Mineralys Therapeutics, Inc. (0001933414) (Filer)” reaches Mineralys Therapeutics (MLYS)
The 19 Oct 2026 story “8-K - Mineralys Therapeutics, Inc. (0001933414) (Filer)” names Mineralys Therapeutics (MLYS) because of this story.
What ties Mineralys Therapeutics (MLYS) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> MLYS
Price levels for Mineralys Therapeutics (MLYS)
MLYS traded between 20.27 and 29.61 across 5 sessions. The latest close on file is 20.88.
How solid “8-K - Mineralys Therapeutics, Inc. (0001933414) (Filer)” looks
36 out of 100Price not final
“8-K - Mineralys Therapeutics, Inc. (0001933414) (Filer)” scores 36 out of 100. The score uses 1 sources, a +3.07% difference versus the S&P 500 (SPY), and 1 linked companies. The price is not final yet.